GRAY-ZONE LYMPHOMA
Clinical trials for GRAY-ZONE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new GRAY-ZONE LYMPHOMA trials appear
Sign up with your email to follow new studies for GRAY-ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive lymphoma: targeted drug combo under study
Disease control Recruiting nowThis early-phase study tests whether adding the targeted drug polatuzumab vedotin (with or without another drug, glofitamab) to standard chemotherapy is safe for people with untreated, aggressive B-cell lymphoma. About 56 participants will receive the combination to see how well …
Matched conditions: GRAY-ZONE LYMPHOMA
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated May 26, 2026 03:53 UTC
-
New combo therapy offers hope for patients with resistant lymphomas
Disease control Recruiting nowThis study tests whether adding ruxolitinib to the immunotherapy drug pembrolizumab is safe and effective for people with certain lymphomas that have come back or not responded to treatment. About 53 adults with Hodgkin or non-Hodgkin lymphoma will receive the combination. The go…
Matched conditions: GRAY-ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: Seda S. Tolu • Aim: Disease control
Last updated May 20, 2026 11:56 UTC